Page last updated: 2024-10-30

meclizine and Leukemia, Myeloid, Acute

meclizine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guan, Y1
Chen, X1
Wu, M1
Zhu, W1
Arslan, A1
Takeda, S1
Nguyen, MH1
Majeti, R1
Thomas, D1
Zheng, M1
Peltz, G1

Other Studies

1 other study available for meclizine and Leukemia, Myeloid, Acute

ArticleYear
The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.
    Journal of hepatology, 2020, Volume: 72, Issue:4

    Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Survival; Drug Therapy, Combination; Female; G

2020